Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Could Be 48% Below Their Intrinsic Value Estimate [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
Current share price of US$448 suggests Vertex Pharmaceuticals is potentially 48% undervalued Analyst price target for VRTX is US$514 which is 40% below our fair value estimate Does the November share price for Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the forecast future cash flows of the company and discounting them back to today's value. The Discounted Cash Flow (DCF) model is the tool we will apply to do this. There's really not all that much to it, even though it might appear quite complex. We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. For those who are keen learners of equity analysis, the Simply Wall St analysis model here may be something of interest to you. See our latest analysis for Vertex Pharmaceuticals We a
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals files automatic mixed securities shelf [Seeking Alpha]Seeking Alpha
- Vertex Pharmaceuticals price target raised to $520 from $460 at Truist [Yahoo! Finance]Yahoo! Finance
- AM Best Assigns Credit Ratings to Torreyana Insurance Company, Inc. [Yahoo! Finance]Yahoo! Finance
- Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast? [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 2/10/25 - Beat
VRTX
Sec Filings
- 2/14/25 - Form 4
- 2/14/25 - Form 4
- 2/14/25 - Form 4
- VRTX's page on the SEC website